Virus therapy teams up with immune drug to attack breast cancer
NCT ID NCT03802604
Summary
This study tested whether injecting a modified virus directly into breast tumors, combined with an immunotherapy drug, could help eliminate remaining cancer cells after standard chemotherapy. The trial involved 28 women with early-stage breast cancer who still had detectable cancer after completing chemotherapy before surgery. Researchers wanted to see if this combination could shrink or eliminate the remaining cancer before patients underwent their planned surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centro Integral Oncológico Clara Campal
Madrid, Madrid, 28050, Spain
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clínico universitario de Valencia
Valencia, Valencia, 46010, Spain
-
Hospital Universitari Vall d'Hebrón
Barcelona, Barcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.